Magellan Diagnostics Announces Voluntary Resolution of Federal Investigation Underlying Product Issues Were Remediated in 2018
BILLERICA, MA, – Magellan Diagnostics, Inc. (Magellan), a Meridian Bioscience, Inc. (Meridian) company, today announced that it has finalized an agreement with the U.S. Department of Justice (DOJ) that resolves the DOJ’s investigation of Magellan. The investigation commenced in 2018 and primarily involved conduct by former Magellan employees that occurred between 2013 and 2017 concerning […]